BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PMN310 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PMN310\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06750432-675@assetmemo.bio
DTSTAMP:20261121T005557Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:PMN310: Phase 1 readout est. (NCT06750432)
DESCRIPTION:PMN310\, phase 1\, Alzheimer's Disease.\nStudy: PMN310 in Patie
 nts With Early Alzheimer's Disease (PRECISE-AD)\nEstimated primary complet
 ion: December 2026. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/p
 mn310#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06750432
URL:https://assetmemo.bio/drug/pmn310#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
